Carlyle Group Reports 8.1% Stake in Soleno Therapeutics as of Oct 8 Vs 9.9% as of Sept 6- SEC Filing
The Carlyle Group報告稱,截至10月8日在soleno therapeutics持有8.1%的股份,而截至9月6日爲9.9%-SEC備案
Carlyle Group Reports 8.1% Stake in Soleno Therapeutics as of Oct 8 Vs 9.9% as of Sept 6- SEC Filing
The Carlyle Group報告稱,截至10月8日在soleno therapeutics持有8.1%的股份,而截至9月6日爲9.9%-SEC備案
譯文內容由第三人軟體翻譯。